The global cancer supportive care drugs market size was reached at USD 19.67 billion in 2022 and it is projected to hit around USD 25 billion by 2031, growing at a CAGR of 2.10% during the forecast period from 2023 and 2031
The rising awareness about adverse effects caused by prolonged cancer treatment is expected to boost the growth of the cancer supportive care drugs market during the forecast period. Cancer supportive care drugs offer wraparound care for cancer patients, and they also help healthcare administration navigate the illness. Cancer supportive care is a well-recognized discipline that plays around...
0 التعليقات 0 المشاركات 435 مشاهدة